Paper - WANFANG MED ONLINE

You Position: Home > Paper

免疫细胞化学p16/Ki-67双染色法在子宫颈癌筛查中应用的研究进展

( views:126, downloads:229 )

Author:: No author available

Journal Title:: Chinese Journal of Obstetrics and Gynecology

Issue:: 11

DOI:: 10.3760/cma.j.issn.0529-567x.2017.11.017

Key Word:: No keyword available

Abstract：子宫颈癌筛查仍然是1项需优先考虑的重大公共卫生问题,满足高质量筛查的基本要求包括初筛的高敏感度及高阴性预测值,同时对初筛阳性者进行合理的分流.这样,才能实现筛查的最大化益处,并且避免对一过性HPV感染及其相应良性病变的不必要干预[1].

Reference

[1]Bergeron C,Klement P,Trunk MJ,etc.The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results.[J].2010,134(1).
[2]Júlio C, Possati-Resende,José H T G, Fregnani,Ligia M, Kerr,etc.The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL.[J].2015,10(7).
[3]Arkadiusz Gertych,Anika O Joseph,Ann E Walts,etc.Automated detection of dual p16/Ki67 nuclear immunoreactivity in liquid-based Pap tests for improved cervical cancer risk stratification.[J].2012,40(5).
[4]Uijterwaal, Margot H.,Polman, Nicole J.,Witte, Birgit I.,etc.Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: Baseline and longitudinal data[J].2015,136(10).
[5]Saraiya,M.,Bornstein,J.,Denny,L.,etc.EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease[J].2012,131(9).
[6]Ikenberg,H.,Bergeron,C.,Schmidt,D.,etc.Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: Results of the PALMS study[J].2013,105(20).
[7].Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesi[J].2000,92(5).
[8]Tokugawa, Diane,Lorey, Thomas,Stiemerling, Eric,etc.Interobserver Reproducibility and Accuracy of p16/Ki-67 Dual-Stain Cytology in Cervical Cancer Screening[J].2014,122(12).
[9]Schmidt D,Bergeron C,Denton KJ,etc.p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.[J].2011,119(3).
[10]Wright, Thomas C., Jr.,Behrens, Catherine M.,Ranger-Moore, James,etc.Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial[J].2017,144(1).
[11].American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer[J].2012,62(3).
[12]Vocaturo,G.,Pescarmona,E.,Rollo,F.,etc.p16/Ki-67 dual staining in cervico-vaginal cytology: Correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy[J].2012,126(2).
[13]Ordi J,Bergeron C,Loning T,etc.Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.[J].2011,121(3).
[14]Loghavi,S.,Walts,A.E.,Bose,S..CINtec? PLUS dual immunostain: A triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion[J].2013,41(7).
[15]NicolasWentzensen,BarbaraFetterman,Philip E.Castle,etc.p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women[J].2015,107(12).
[16]Alameda, Francisco,Ridder, Ruediger,Rehm, Susanne,etc.Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results[J].2015,123(6).
[17]M H Uijterwaal,B I Witte,F J Van Kemenade,etc.Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study.[J].2014,110(6).
[18]Fujii, Takuma,Saito, Miyuki,Hasegawa, Toshihiko,etc.Performance of p16(INK4a)/Ki-67 immunocytochemistry for identifying CIN2+in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study[J].2015,20(1).
[19]Kisser, A.,Zechmeister-Koss, I..A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology[J].2015,122(1).
[20]Bulten J,Horvat R,Jordan J,etc.European guidelines for quality assurance in cervical histopathology.[J].2011,50(5).
[21]Jeffrey L. Killeen,Timothy Dye,Chelestes Grace,etc.Improved Abnormal Pap Smear Triage Using Cervical Cancer Biomarkers[J].2014,18(1).
[22]Lu-Lu, Yu,Wen, Chen,Xiao-Qin, Lei,etc.Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.[J].2016.